Advertisement

American Society of Nephrology, Oct. 23-27

0
By Beth Gilbert HealthDay Reporter The annual meeting of the American Society of Nephrology (Kidney Week) was held this year from Oct. 23 to 27 in San...

Policies About Late-Career Physicians Are Considered Successful

0

Policies varied in the testing required, funding, processes after a positive screening result, and decision-making around concerning results

Uninsurance Plays Major Role in Racial Disparities Seen in Cancer Diagnosis

0

Lack of insurance accounts for significant proportion of racial, ethnic disparities in stage III to IV diagnoses across range of cancers

ASN: 1990 to 2021 Saw Global Rise in Chronic Kidney Disease Cases, Deaths in...

0

Type 2 diabetes and hypertension were the major contributors to chronic kidney disease-related deaths among women in 2021

Small but Important Differences Seen Between Rosuvastatin, Atorvastatin

0

Rosuvastatin tied to cardiovascular and mortality benefits but also higher risk for type 2 diabetes

ASN: Atrasentan Significantly and Clinically Meaningfully Cuts Proteinuria

0

Findings seen in patients with IgA nephropathy, compared with placebo

ASN: Hypertension Most Common Cardiovascular Comorbidity Seen With Dialysis

0

The next most common conditions included atherosclerotic heart disease and congestive heart failure

Many Seniors at Risk for Financial Precarity From Cost of Hospital Stay

0

Financial precarity more prevalent among Black and Hispanic versus White, those with less versus more than high school education

ASN: Recurrent UTIs Impact eGFR in Children With Vesicoureteral Reflux

0

Recurrent urinary tract infections linked to decrease of up to 27 mL/min/1.73 m² in estimated glomerular filtration rate

ASN: Empagliflozin Offers Lasting Cardiorenal Benefit in CKD Patients

0

Empagliflozin offers cardiorenal benefits for up to 12 months after discontinuation among CKD patients at risk for progression